Pebble Biotechnology Laboratories

Biotechnology
Early Growth
2021

Pebble Biotechnology Laboratories (“PBL”) is a company based on 20+ years of pioneering NHS organ transplant research, which is now providing ex-vivo organ perfusion services to the commercial market. PBL’s specialist team will do this using the practical perfusion skills developed within the NHS, academic research, and through links with leading international research groups. The technology holds the potential to fundamentally change costs, timescales and development pathways of the complex in-vivo testing programmes that are used to generate large scale pre-clinical data for the life sciences industry.

PBL offers a highly specialised skillset in a novel emerging market with potential to benefit the global med-tech and pharma markets. Furthermore, the company has a pipeline of technologies that they intend to advance, providing further benefits back to their customers, and potentially the wider patient population.

Our Approach

What do we look for?

Our business is about forming long term relationships with exceptional entrepreneurs and becoming a trusted partner and supportive investor.

We look for companies with both the vision and potential to become ‘game changers’ and market leaders across a range of sectors.

learn more

Our Team

Anne Freeman

view complete team

Contact us

Binder House
7 Narborough Wood Park
Desford Road
Enderby
Leicester
LE19 4XT

Tel: 0116 238 8200

email